Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer's disease

Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer’s disease

Tau has develop into a lovely different goal for passive immunotherapy efforts for Alzheimer’s illness (AD). The anatomical distribution and extent of tau pathology correlate with illness course and severity higher than different illness markers up to now. We describe right here the technology, preclinical characterization, and section 1 scientific characterization of semorinemab, a¬†humanized anti-tau…

Read More